PIDGIN specifications

Information


Unique identifier OMICS_20628
Name PIDGIN
Alternative name Prediction IncluDinG INactivity
Software type Application/Script
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux, Mac OS
Programming languages Python
License MIT License
Computer skills Advanced
Version 2.0
Stability Stable
Maintained Yes

Download


download.png

Versioning


No version available

Maintainers


  • person_outline Lewis Mervin
  • person_outline Andreas Bender

Publications for Prediction IncluDinG INactivity

PIDGIN citations

 (2)
library_books

Computer aided design of multi target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases

2017
J Cheminform
PMCID: 5748027
PMID: 29290010
DOI: 10.1186/s13321-017-0249-4

[…] argest), “Neutralize”, “RemoveExplicitH”, “Clean2D”, “Mesomerize” and “Tautomerize” []. The standardized canonical SMILES were exported to CSV files, and subjected to enriched target prediction using PIDGIN 1.0 implementing the method developed by Liggi et al. [, ]. The target prediction for the designed RECAP library was performed using a recall probability threshold of 0.01 (which is a value con […]

library_books

Implications of the cattle trade network in Cameroon for regional disease prevention and control

2017
Sci Rep
PMCID: 5339720
PMID: 28266589
DOI: 10.1038/srep43932

[…] semi-structured interviews were conducted with the veterinary officials and market managers using French and English (Cameroonian official languages) and two local languages (Fufulde and Cameroonian Pidgin). Interviewees were asked to identify all the origins and destinations of traded animals, as well as the weights of these connections, defined as the number of traded animals per month. Data so […]

PIDGIN institution(s)
Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, UK; Oncology Innovative Medicines and Early Development, AstraZeneca, Cambridge, UK; Discovery Sciences, AstraZeneca R&D, Cambridge Science Park, UK; Discovery Sciences, AstraZeneca R&D Gothenburg, Molndal, Sweden
PIDGIN funding source(s)
Supported by the Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K011804/1] and AstraZeneca.

PIDGIN reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review PIDGIN